Berkeley, CA, United States of America

Aduro Gvax Inc.

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 20.0



Trademarks = 1

Forward Citations = 38

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Karin Ute Jooss (3 out of 22 patents)

silverMedal Minh Nguyen (2 out of 9 patents)

bronzeMedal Thomas Harding (2 out of 11 patents)

4.  David W Frey (2 out of 15 patents)

5.  Andy Lin (2 out of 3 patents)

6.  Gautum Banik (2 out of 2 patents)

7.  Kathryn E Koprivnikar (2 out of 3 patents)

8.  Alan J Korman (1 out of 88 patents)

9.  Betty Li (1 out of 3 patents)

10.  James P Allison (4 patents)

11.  Andrew Simmons (7 patents)


5 patents:

Company Overview
Aduro Gvax Inc. is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies. The company's lead product candidate is ADU-S100, a STING pathway activator for the treatment of solid tumors. Aduro is committed to transforming the treatment landscape for cancer patients through its innovative approach to immunotherapy.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#95 in Berkeley, CA

#12,079 in California

#51,669 in US

Berkeley, CA (US)
Berkeley, CA, United States of America
Forward Citations = 38

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aduro Gvax Inc.. Retrieved from https://idiyas.com/company/aduro-gvax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…